Regencell Bioscience Holdings Limited RGC
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 189.82% | 189.82% | -- | -- | -38.49% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 429.31% | 429.31% | -- | -- | -96.20% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 190.10% | 190.10% | -64.21% | -64.21% | -39.58% |
|
|
|||||
| Total Current Assets | 190.10% | 190.10% | -64.21% | -64.21% | -39.58% |
| Net Property, Plant & Equipment | -43.31% | -43.31% | -- | -- | 235.45% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -18.60% | -18.60% | -89.54% | -89.54% | -4.81% |
| Total Assets | 155.92% | 155.92% | -59.71% | -59.71% | -31.79% |
|
|
|||||
| Total Accounts Payable | -- | -- | -- | -- | -- |
| Total Accrued Expenses | 208.15% | 208.15% | -- | -- | 178.05% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -24.46% | -24.46% | -- | -- | 423.08% |
| Total Finance Division Other Current Liabilities | 332.00% | 332.00% | -- | -- | -70.24% |
| Total Other Current Liabilities | 332.00% | 332.00% | -- | -- | -70.24% |
| Total Current Liabilities | 98.99% | 98.99% | -- | -- | 242.82% |
|
|
|||||
| Total Current Liabilities | 98.99% | 98.99% | -- | -- | 242.82% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -74.31% | -74.31% | -- | -- | 794.21% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 54.16% | 54.16% | 134.88% | 134.88% | 307.88% |
|
|
|||||
| Common Stock & APIC | 66.96% | 66.96% | 372.99% | 372.99% | 0.82% |
| Retained Earnings | -46.43% | -46.43% | -- | -- | -16.58% |
| Treasury Stock & Other | 30.09% | 30.09% | -- | -- | -41.48% |
| Total Common Equity | 174.66% | 174.66% | -81.84% | -81.84% | -40.86% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 174.66% | 174.66% | -81.84% | -81.84% | -40.86% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 174.66% | 174.66% | -81.84% | -81.84% | -40.86% |
|
|
|||||